Evidence map›Paper›PMID 41668855›Full record

ArticleHealthcare technology letters

Automated Diagnosis of Hypertensive Retinopathy Using Res-UNet and Graph Convolutional Networks.

Esra'a Mahmoud Jamil Al Sariera

Abstract read
In one paragraph

Article in Healthcare technology letters. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Esra'a Mahmoud Jamil Al SarieraDepartment of Computer Science Faculty of Information Technology Al-Ahliyya Amman University Amman Jordan.ORCID https://orcid.org/0009-0003-8994-674X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertensive retinopathy (HR), a progressive retinal condition, is associated with both hypertension and diabetes mellitus. The development of HR is closely correlated with the severity and duration of hypertension. The results of the HR indicate that pathological eye issues include cotton-like spots, macular oedema, constrained arterioles and retinal haemorrhage. An ophthalmologist would still often undertake a manual physical examination using an ophthalmoscope to detect HR in a patient's body. It is time-consuming for a physician to identify HR in a patient based only on retina fundus imaging when done manually. An automated approach for identifying the retinal fundus image is required to solve this issue. One crucial component in the diagnosis of many eye diseases is the condition of the blood vessels in the retina. Researchers have found great interest in the blood vessel segmentation of fundus images for this reason. The knowledge of blood vessel changes associated with various disorders, such as cardiovascular diseases and retinopathy, depends on the accurate segmentation of arteries and veins (A/V) from fundus images. The arteriovenous ratio displays the proportion of vein to artery diameters. The precision with which vessels are divided into veins and arteries determines the significance of this measure. To increase the accuracy of classifying retinal blood vessels and HR phases, a novel technique combining deep residual UNET (Res-UNet) and a graph convolutional network is suggested in this research. Pre-processing (green channel, contrast-restricted adaptive histogram equalisation) was done before identification. Graphs are used to depict the features of the vessel that are extracted from the spatial domain. The DRIVE-AV image dataset is used to execute the proposed approach and the results show that the system achieves a blood vessel segmentation accuracy of 96.45% and an A/V classification of 96.7%.

Indexed as

blood vesselseyefeature extractionhealth careimage classificationimage processingimage segmentationmedical image processing

Identifiers

PMID41668855
PMCPMC12884679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.